FDA Plans to Speed Up Drug Trials With Real-Time Data, AI

The US Food and Drug Administration plans to cut the time it takes drug companies to test new medicines by getting more visibility into clinical trials as they’re underway.

The proposal could shave off “months, if not years” off of drug development times, the agency’s Chief AI Officer Jeremy Walsh said on a call with reporters. Under the plan, the FDA will monitor high-level signals about whether experimental drugs work and are safe in real time, though it won’t collect all patient-level data.

The announcement is part of the agency’s broader agenda to make the US more competitive for drug ...